Original filing (PDF)20250929144304NAL0012315744001

PATHOLOGYOUTLINES.COM, INC.

Name: PATHOLOGYOUTLINES.COM, INC. — PATHOLOGYOUTLINES.COM, INC. CASH BALANCE PLAN, Form 5500 (2024)
Creator: PATHOLOGYOUTLINES.COM, INC.

Form 5500-SF

FILING_RECEIVED

PATHOLOGYOUTLINES.COM, INC. CASH BALANCE PLAN

Defined-benefit pension plan

Active participants

Accounts w/ balance

—

Plan assets (EOY)

$2.2M

Net assets (EOY)

$2.2M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for PATHOLOGYOUTLINES.COM, INC..

Plan sponsor

Name

PATHOLOGYOUTLINES.COM, INC.

EIN

20-5392641

Address

30150 TELEGRAPH ROAD SUITE #119 · BINGHAM FARMS, MI · 48025

Phone

(248) 646-0325

Industry

Health Care & Social Assistancesee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

002

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-09-29

Pension benefit codes

1C · Cash balance or similar hybrid DB

3D · Pre-approved plan (master / prototype / VS)

Audit & trust (Schedule H)

Auditor

—

Trustee / custodian

—

Trustee phone

—

Small plan (5500-SF) — Schedule H data not available.

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Health Care & Social Assistance plans

THE KHADER GROUP, INC.

THE KHADER GROUP, INC. PROFIT SHARING 401(K) PLAN

$2.2M · 3 participants

DR. LUIS F. VIERA CABAN AND LUIS F. VIERA CABAN, C.S.P.

DR. LUIS F. VIERA CABAN RETIREMENT PLAN SERIES 94-884

$2.2M · 6 participants

BIONIC PROSTHETICS & ORTHOTICS

$2.2M · 136 participants

JOHN K. WILDEMORE, M.D., LLC

JOHN K. WILDEMORE, M.D., LLC 401(K) RETIREMENT PLAN

$2.2M · 9 participants

ROCHESTER CLINICAL RESEARCH, INC.